Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | MIF | P14174 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14975715 | 0.92 | HDAC4 (0.47) | ADRB2ADRB1MIFHTR2AADRA1A | |
| SCHEMBL14847092 | 0.92 | HDAC4 (0.47) | ADRB2ADRB1MIFHTR2AADRA1A | |
| Hydrochloric Acid SCHEMBL14157499 | 0.90 | ALDH1A1 (0.45) | ADRB2ADRB1MIFHTR2AADRA1A | |
| Hydrochloric Acid SCHEMBL14122255 | 0.90 | ALDH1A1 (0.45) | ADRB2ADRB1MIFHTR2AADRA1A | |
| SCHEMBL30137615 | 0.90 | ADRB1 (0.39) | ADRB2ADRB1MIFHTR2AADRA1A | |
| SCHEMBL23520554 | 0.90 | ADRB1 (0.39) | ADRB2ADRB1MIFHTR2AADRA1A | |
| SCHEMBL4550414 | 0.90 | ADRB1 (0.39) | ADRB2ADRB1MIFHTR2AADRA1A | |
| Hydrochloric Acid SCHEMBL23247079 | 0.88 | ALDH1A1 (0.39) | ADRB2ADRB1MIFHTR2AADRA1A | |
| SCHEMBL20327099 | 0.88 | KMT2A (0.47) | ADRB1MIFHTR2AADRA1AHTR2B | |
| SCHEMBL23809909 | 0.88 | KMT2A (0.47) | ADRB1MIFHTR2AADRA1AHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543850-A1 | METHOD FOR PRODUCING ISOCYANTES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES | Covestro Deutschland AG (DE) | 2025-04-30 | — | — | EP | claimed |
| US-20250066650-A1 | Epoxy Resin Adhesives | GURIT UK LTD (GB) | 2025-02-27 | — | — | US | claimed |
| EP-4370579-A1 | HARDENER FOR EPOXY RESINS | Sika Technology AG (CH) | 2024-05-22 | — | — | EP | claimed |
| WO-2023247522-A1 | METHOD FOR PRODUCING ISOCYANTES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES | COVESTRO DEUTSCHLAND AG (DE) | 2023-12-28 | — | — | WO | claimed |
| US-11786860-B2 | Solvent composition for CO2 capture and a process mediated thereof | INDIAN OIL CORPORATION LIMITED (IN) | 2023-10-17 | — | — | US | claimed |
| WO-2023089122-A1 | EPOXY RESIN ADHESIVES | GURIT (UK) LTD (GB) | 2023-05-25 | — | — | WO | claimed |
| WO-2023285189-A1 | HARDENER FOR EPOXY RESINS | SIKA TECHNOLOGY AG (CH) | 2023-01-19 | — | — | WO | claimed |
| US-11471821-B2 | Process for biogas upgradation | INDIAN OIL CORPORATION LIMITED (IN) | 2022-10-18 | — | — | US | claimed |
| US-20220325150-A1 | Epoxy Resin Adhesives | GURIT (UK) LTD. (GB) | 2022-10-13 | — | — | US | claimed |
| EP-4007785-A1 | EPOXY RESIN ADHESIVES | Gurit (UK) Ltd. (GB) | 2022-06-08 | — | — | EP | claimed |
| US-20220072472-A1 | SOLVENT COMPOSITION FOR CO2 CAPTURE AND A PROCESS MEDIATED THEREOF | INDIAN OIL CORPORATION LIMITED (IN) | 2022-03-10 | — | — | US | claimed |
| EP-3964279-A1 | SOLVENT COMPOSITION FOR CO2 CAPTURE AND A PROCESS MEDIATED THEREOF | Indian Oil Corporation Limited (IN) | 2022-03-09 | — | — | EP | claimed |
| WO-2021048282-A1 | EPOXY RESIN ADHESIVES | GURIT (UK) LTD (GB) | 2021-03-18 | — | — | WO | claimed |
| US-20090215762-A1 | Siloxane polymer containing tethered levofloxacin | NDSU RESEARCH FOUNDATION | 2009-08-27 | — | — | US | claimed |
| US-20250376438-A1 | METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-11 | — | — | US | disclosed |
| EP-4543850-A1 | METHOD FOR PRODUCING ISOCYANTES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES | Covestro Deutschland AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20250066650-A1 | Epoxy Resin Adhesives | GURIT UK LTD (GB) | 2025-02-27 | — | — | US | disclosed |
| EP-0216213-A2 | Discoloration inhibitor for aromatic amines | ETHYL CORPORATION (US) | 1987-04-01 | — | — | EP | disclosed |
| US-4473375-A | COUPLER AND DEVELOPER FOR OXIDATION COLOR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | disclosed |
| US-4324553-A | OXIDATION COLOR DYES | L'OREAL (FR) | 1982-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250376438-A1 | METHOD FOR PRODUCING ISOCYANATES VIA PHOSGENATION OF A MIXTURE OF (AR)ALIPHATIC DIAMINES AND CYCLOALIPHATIC DIAMINES | APEH, CDIPT, DDT | ADRB2 1077/4885ADRB1 1384/4885MIF 4760/4885 |
| US-20090215762-A1 | Siloxane polymer containing tethered levofloxacin | PUF60, QARS1, SEPTIN7 | ADRB2 4107/4885ADRB1 3976/4885MIF 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.